Founded with a mission to revolutionize antimicrobial technology, Novālent focuses on providing long-lasting protection against microorganisms. Their core product is a groundbreaking antimicrobial solution that inhibits microbial growth for up to 90 days with a single application. This product is registered with the EPA and approved for use on food contact surfaces, making it suitable for various industries, including healthcare, food service, and consumer goods.
Novālent has garnered trust from leading global brands and has demonstrated its effectiveness through extensive field trials. The company's team comprises experts in microbiology and material science, contributing to its innovative edge. Notable investors have supported Novālent's growth, enabling it to achieve significant market penetration and impact. By extending the efficacy of antimicrobial treatments, Novālent has set new standards in hygiene and public health.
